Do young adults actually need GHK-Cu? What the science says

What's this video probably claiming?

Based on the caption and hashtags, @smoneyyz appears to be pushing back against the growing trend of young adults, specifically college-aged people in their early twenties, rushing to use GHK-Cu copper peptides and other bioactive peptides as anti-aging or skin-rejuvenation tools. The creator is likely arguing that peptide therapy of this kind is unnecessary at that life stage, possibly because endogenous peptide levels and collagen synthesis are still strong in young adults. This is a reasonable position to stake out, given how aggressively peptide supplements and compounded injectables get marketed on TikTok to anyone who will buy them. The question worth asking: is this a genuinely evidence-informed take, or is it overcorrecting in the other direction by implying peptides are only for older users?

What does the science actually show?

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide found in human plasma. Concentrations are highest in young adults, roughly 200 ng/mL in plasma at age 20, and decline to around 80 ng/mL by age 60, according to Pickart and Margolina (2018, Symmetry). That decline in endogenous GHK-Cu is associated with reduced collagen synthesis, slower wound healing, and changes in gene expression patterns tied to tissue repair. Topical GHK-Cu has demonstrated efficacy in several controlled studies, including Leyden et al. (1994, Skin Pharmacology) showing measurable improvements in skin thickness and elasticity after 12 weeks of use. However, essentially all meaningful clinical data involves adults aged 40 and older, where endogenous levels are meaningfully suppressed. There is no controlled trial demonstrating that supplementing GHK-Cu in people with already-optimal endogenous levels produces additional benefit.

Where does the social media noise diverge from clinical reality?

The peptide content ecosystem on TikTok treats GHK-Cu like a universal upgrade, a tool anyone can layer on for better skin, faster recovery, or systemic anti-aging effects regardless of baseline biology. That framing ignores a basic concept in pharmacology: if your body is already producing adequate amounts of a signaling peptide and your receptors are responding normally, exogenous supplementation does not necessarily produce additive effects. It may do nothing measurable. The creator's instinct to push back on this is directionally correct. Where the discourse gets murkier is the broader claim about all peptides. Some peptides like BPC-157 are studied for injury repair contexts that genuinely affect young athletes, and the physiology there is different from age-related GHK-Cu decline. Grouping all peptides into one blanket recommendation oversimplifies a genuinely complicated category of compounds with very different mechanisms and evidence profiles.

What should you actually know?

If you are in your early twenties, your endogenous GHK-Cu production is likely near its lifetime peak. Adding more via a topical serum is low-risk and possibly useless for most people in that age group. Adding it via injectable or oral compounded formulations introduces regulatory and purity considerations that are not trivial, and the risk-benefit calculation shifts significantly when the biological need is unclear. The creator's core message, that young adults are being upsold on interventions they do not need, is defensible and worth hearing. But anyone watching this video should understand that the science on GHK-Cu is not settled for any age group. Most studies are small, short-term, and industry-adjacent. A dermatologist or a clinician familiar with peptide pharmacology is a better resource than a TikTok trend cycle. Decisions about any peptide protocol, topical or systemic, should involve a licensed provider who can assess your actual baseline.